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Background: Although women represent an increasing proportion of those presenting with abdominal
aortic aneurysm (AAA) rupture, the current prevalence of AAA in women is unknown. The contemporary
population prevalence of screen-detected AAA in womenwas investigated by both age and smoking status.
Methods: A systematic review was undertaken of studies screening for AAA, including over 1000 women,
aged at least 60 years, done since the year 2000. Studies were identified by searching MEDLINE, Embase
and CENTRAL databases until 13 January 2016. Study quality was assessed using the Newcastle–Ottawa
scoring system.
Results: Eight studies were identified, including only three based on population registers. The largest
studies were based on self-purchase of screening. Altogether 1 537 633 women were screened. Overall
AAA prevalence rates were very heterogeneous, ranging from 0⋅37 to 1⋅53 per cent: pooled prevalence
0⋅74 (95 per cent c.i. 0⋅53 to 1⋅03) per cent. The pooled prevalence increased with both age (more than
1 per cent for women aged over 70 years) and smoking (more than 1 per cent for ever smokers and over
2 per cent in current smokers).
Conclusion: The current population prevalence of screen-detected AAA in older women is subject to
wide demographic variation. However, in ever smokers and those over 70 years of age, the prevalence is
over 1 per cent.
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Introduction
Previously abdominal aortic aneurysm (AAA) has been con-
sidered a male-dominated disorder, with four to six times
more men than women receiving both elective and emer-
gency AAA repair, and epidemiological studies showing
that the prevalence of AAA was three to six times higher in
men than in women1–3.Women tend to develop AAA later
in life than men4,5. Population screening for AAA in men
has been introduced in several countries, to reduce mortal-
ity from ruptured AAA6. However, today almost one-third
of the patients presenting to hospital with ruptured AAA
are women and their mortality is very high, so that women
are contributing an increasing proportion of AAA deaths7,8.
Therefore, it is questionable whether women are being
offered appropriate diagnosis and adequate management of
their AAA9.
Smoking is the strongest risk factor for AAA, the asso-
ciation being much stronger than that between smoking
and other forms of cardiovascular disease10. Historically,
women took up smoking in large numbers some 15–20
years after men, and several studies11–13 suggest that today
the prevalence of smoking may be higher in women than
in men. There has been a steady decline in the preva-
lence of smoking over the past 25–30 years, most notably
among men, which has been linked to a declining preva-
lence of screen-detected AAA in men, from 4–5 per cent
in the 1990s to about 1–2 per cent today14,15. Other fac-
tors, including themorewidespread use of diagnostic imag-
ing leading to an increasing incidental detection of AAA,
could also have contributed to the declining prevalence
of screen-detected AAA in men. There are far fewer data
available for women. This study is a systematic review of
contemporary (2000 or later) AAA screening studies in
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women, to assess the population prevalence, and determine
how this may vary with age and smoking status.
Methods
This systematic review was conducted according to
the PRISMA guidelines16, and registered in May
2015 in the PROSPERO database (http://www.crd.
york.ac.uk/PROSPERO/; registration number CRD42
015020444). The review protocol was reviewed externally
(F. Lederle, Veterans Administration Hospital, Minnea-
polis, Minnesota, USA). The aim was systematically to
review published and unpublished data of the current
(since 2000) prevalence of AAA in women, detected by
either ultrasonography or CT (aortic diameter 3⋅0 cm or
greater).
MEDLINE, Embase and CENTRAL databases were
searched, using a combination of controlled vocabu-
lary (medical subject heading (MeSH) or Emtree®)
terms and free-text terms in ProQuest Dialog™,
and limiting the search to data published since 2000.
The search was restricted to major European lan-
guages, and used the following terms: abdominal aortic
aneurysm, women/gender/sex/women’s health/sex dif-
ference, genetic predisposition, prevalence/incidence/
occurrence/frequency, screening, population/population-
based. The final search date was 13 January 2016.
Clinicaltrials.gov (http://clinicaltrials.gov), Current
Controlled Trials (http://www.controlled-trials.com/) and
the National Research Register (UK) were also searched
for details of ongoing or unpublished trials. This search
was complemented by scanning reference lists of relevant
articles, and manual searches of Endovascular Today and
vascular surgery conference proceedings.
Study selection
The inclusion and exclusion criteria are shown in Table 1.
The initial rejection or inclusion was based on the study
title; review articles were retained for examination of their
references.
Full-text versions of the selected shortlist of documents
were obtained. Two reviewers assessed them individually
to make sure they adhered to the initial eligibility criteria
and then selected studies that met the inclusion criteria.
Differences of opinion were resolved by discussion.
Data extraction and quality scoring
A data extraction form, which identified demographic
and technical details, and potential biases, in the selected
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Screening date year 2000 onwards Review articles
Women≥60 years of age Editorials
All ethnic groups Letters
Population described clearly Case reports
Screening of≥1000 women Studies of people with
known cardiovascular
disease
For studies reporting duplicated
data, the most recent or most
comprehensive publication to
be included
Ultrasonography or CT for aortic
diameter measurement
studies, was designed by the reviewers and approved by
the full study team. A summary checklist was completed
for each study. For four publications, study authors were
contacted to request additional information to enable com-
pletion of the checklist. Three authors/studies provided
the requested data. Quality scoring was undertaken using
the Newcastle–Ottawa scale for cross-sectional studies17.
Criteria for quality assessment are detailed in the protocol
(http://www.crd.york.ac.uk/PROSPEROFILES/20444_
PROTOCOL_20160426.pdf).
The following data were extracted independently by the
two reviewers: study design, screening setting (includ-
ing number of centres) and country, AAA screening start
and end dates, screening method, AAA definition, popula-
tion description of women (including ethnicity, age range,
smoking and diabetes), exclusion criteria (particularly when
the study excluded non-screen-detected/known AAA or
previous AAA repairs), number of women invited to be
screened, number of womenwho accepted screening, num-
ber of women with AAA (including AAA detection by age
and smoking status), and authors’ reported limitations of
the study.
Data synthesis and analysis
An estimate of the prevalence was made from each study,
calculated as the number of women with AAA divided
by the number of women who were screened success-
fully. A 95 per cent confidence interval (c.i.) for the
prevalence in each study was calculated using the score
confidence interval18,19. Three studies20–22 included
women younger than 60 years of age in their screening. As
the present review excludes younger women, only those
aged 60 years and above from these studies were included.
A random-effects meta-analysis was performed on the
logit probability scale (with standard errors transformed
using the δmethod) using the method of DerSimonian and
Laird23. Heterogeneity was assessed using the I2 statistic24.
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Citations identified from literature search n = 92
 MEDLINE n = 50
 Embase n = 30*
 CENTRAL n = 3
 Other sources (search engines) n = 9
Potentially relevant articles identified for further
full-text review n = 24
Included in meta-analysis
 Published studies n = 7
 Unpublished data set n = 1
Excluded based on titles or abstracts using general
criteria n = 68
 Not relevant or not population-level n = 60
 Other publication or study type (editorial, review) n = 7
 Full text not available (Japanese article) n = 1
Excluded n = 17
 Did not meet inclusion criteria n = 14
 AAA detection rates not reported n = 1
 Incomplete report n = 1
 Duplicate subjects n = 1Articles identified from reference lists n = 2
Unpublished data set provided by the author n = 1
Excluded from meta-analysis n = 2
 Subgroup study n = 1
 Reporting minimum prevalence only n = 1
Fig. 1 Flow diagram of included studies. *Five duplicates between MEDLINE and Embase removed. AAA, abdominal aortic aneurysm
Further exploration of between-study heterogeneity was
investigated by meta-regression. Results are presented as
forest plots.
Results
A total of 92 unique articles were identified, of which 24 (26
per cent) were considered potentially relevant and assessed
in detail (Fig. 1). Six papers based on six studies met the
inclusion criteria20,21,25–28 and a seventh study22 reported
on AAA defined as diameter of 3⋅5 cm or more, but data
for women with aortic diameter of 3⋅0 cm or over were
obtained from the corresponding author. All these studies
used ultrasonography for screening. Correspondence with
the authors provided further details of several studies21,25,26
and one author25 provided an eighth unpublished study
using ultrasonography for screening. These eight studies
were included in the meta-analysis. One study29 reported
on a subgroup of a larger study, and was retained for
assessment of prevalence by smoking status only. One fur-
ther medium-sized study30 reported on physician-initiated
screening (with both ultrasonography and CT) in a pop-
ulation, but without defining either the specific criteria
for screening or AAA by a minimum aortic diameter, and
hence provides only a minimum estimate of prevalence.
All of the studies excluded women with known AAA from
screening.
Of the 17 studies that were excluded after reviewing
the full text, two did not meet the inclusion criteria as
they had screened fewer than 1000 women: 795 women31
and 796 women32. Three large studies were excluded:
one33 consisted of a selected population (including 14 834
Chinese women with hypertension) and the other two34,35
had been carried out in 1992 and between 1992 and 1997
respectively. A recent French study36 provided insufficient
information.
The characteristics of the included studies are summa-
rized in Table 2. Two studies20,21 of very large cohorts were
identified (about 1⋅4 and 0⋅9million women aged at least 60
years respectively), mainly self-referred for self-purchased
Life Line screening, from the USA and Great Britain
and Ireland. The US Life Line screening data included
a minority of subjects (7⋅0 per cent) with at least one
cardiovascular risk factor, put forward for sponsored Life
Line screening; this minority was reported on separately by
Derubertis and colleagues29. These latter data were used to
assess the effect of smoking on AAA prevalence, as this was
not reported in the overall USALife Line cohort20. Smaller
studies offering free screening based on population regis-
ters were from Sweden27, Norway22 and Italy28, but only
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Table 2 Characteristics of included studies, ordered by date of screening
Reference Selection for screening
Screening
dates Country
No. of women
screened
(% attendance)
Age range
(years)
Never smoked
(current
smokers) (%)
N-O
score*
No. of
AAAs
(% prevalence)
Forsdahl et al.22 Population-based, free 2001 Norway 1956 (85†) 61 to≥80 35 (25) 9 30 (1⋅53)
Ogata et al.26 Self-referred, free 2001–2004 USA 1298 (n.a.) 60–89 n.a. (9⋅2) 5 19 (1⋅46)
Hupp et al.25 Self-referred, free 2000–2006 USA 4982 (n.a.) 60–89 n.a. 7 47 (0⋅94)
Savji et al.20‡ Mainly self-referred,
self-purchased
2003–2008 USA 1428316 (n.a.) 61–100 n.a. 6 6229 (0⋅44)
Hupp (unpublished) Self-referred, free 2006–2008 USA 3060 (n.a.) 66–105 22 (n.a.) 7 28 (0⋅92)
Svensjo et al.27 Population-based, free 2007–2009 Sweden 5140 (74) 70 56 (10) 9 19 (0⋅37)
Palombo et al.28 Population-based, free 2007–2009 Italy 3907 (48) ≥ 65 n.a. 7 43 (1⋅10)
Bulbulia et al.21 Self-referred,
self-purchased
2008–2012 UK, Ireland 88 974 (n.a.) 60 to≥80 n.a. 6 278 (0⋅31)
Jahangir et al.30§ Physician-initiated,
reimbursed
2002–2009 USA 11815 (n.a.) ≥ 65 42 (21) 5 123 (1⋅04)
*Newcastle–Ottawa scale (N-O), used to assess study quality; highest scores represent the best quality studies (http://www.ohri.ca/programs/
clinical_epidemiology/oxford.asp). †Similar numbers of men and women screened; overall uptake 85 per cent. ‡Does not report aneurysm size and
smoking; used for prevalence only owing to the very large population of women and supplemented by data from Derubertis and colleagues29, who also
used the same Life Line screening, but provided data on a subgroup of 10 012 women, mean age 69 years, with at least one cardiovascular risk factor,
screened between 2004 and 2006. §Physician-initiated screening study reporting only minimum prevalence; not included in data synthesis, but outline
details are provided for comparison with a group of lower socioeconomic status. AAA, abdominal aortic aneurysm; n.a., not available.
Forsdahl et al.22
Reference Prevalence (~)
1·53 (1·07, 2·19)
1·46 (0·94, 2·28)
0·94 (0·71, 1·25)
0·44 (0·43, 0·45)
0·92 (0·63, 1·32)
0·37 (0·24, 0·58)
1·10 (0·82, 1·48)
0·31 (0·28, 0·35)
0·74 (0·53, 1·03)
12·12
11·20
12·78
14·11
12·01
11·23
12·67
13·88
100·00
Weight (~)
Ogata et al.26
Hupp et al.25
Savji et al.20
Hupp (unpublished) 
Svensjo et al.27
Palombo et al.28
Bulbulia et al.21
Pooled overall (I2 = 96·3~)
Prevalence (~)
2·01·51·00·50
Fig. 2 Pooled prevalence of abdominal aortic aneurysm in women aged at least 60 years: eight studies with screening performed between
2001 and 2012. Values in parentheses are 95 per cent confidence intervals
two of these were of very high quality, and in total this type
of study contributed only 11 003 women. There were two
further published studies25,26 and one unpublished study
offering, by advertisement, sponsored free screening in
the USA. This gave an overall total of 1 537 633 women
screened in eight separate studies, with a pooled preva-
lence of AAA of 0⋅74 (95 per cent c.i. 0⋅53 to 1⋅03) per
cent in women aged at least 60 years, but with considerable
heterogeneity (Fig. 2).
The lowest prevalence (0⋅31 per cent) was observed in
the large UK and Ireland Life Line study21 of self-referred
individuals paying for screening. Otherwise the overall
prevalence of AAA ranged from 0⋅37 per cent in Sweden to
1⋅53 per cent in Norway (both studies based on population
registers). The Life Line screening of predominantly
self-referred women purchasing screening yielded similar
low AAA prevalence in the USA (0⋅44 per cent) and in
Great Britain and Ireland (0⋅31 per cent). The study of a
large predominantly uninsured and ethnically diverse US
population aged 65 years and over, in which almost half of
the women smoked, reported a minimum prevalence of
1⋅04 per cent30 (Table 2).
The pooled prevalence of AAA increased rapidly
with age: 0⋅43 per cent at 61–70 years, 1⋅15 per cent
in those 71–80 years and 1⋅68 per cent in those aged
81 years or more (Fig. 3). However, there was considerable
© 2016 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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Forsdahl et al.22
Age 71–80 years
Reference Prevalence (~)
1·13 (0·66, 1·94)
1·05 (0·52, 2·08)
0·25 (0·12, 0·52)
0·23 (0·22, 0·24)
0·19 (0·05, 0·76)
0·37 (0·24, 0·58)
0·43 (0·23, 0·80)
2·02 (1·24, 3·27)
1·88 (0·94, 3·71)
1·83 (1·29, 2·58)
0·60 (0·58, 0·62)
0·50 (0·27, 0·93)
1·15 (0·59, 2·24)
7·14 (1·00, 37·03)
2·78 (0·90, 8·26)
1·97 (1·03, 3·73)
1·01 (0·96, 1·06)
1·69 (1·06, 2·66)
1·68 (1·02, 2·74)
17·86
16·49
16·06
20·58
10·36
18·65
19·92
18·01
22·29
21·01
18·77
5·17
12·30
21·60
34·35
26·58
Weight (~)
Ogata et al.26
Hupp et al.25
Savji et al.20
Hupp (unpublished) 
Subtotal (I2 = 94·4~)
Forsdahl et al.22
Age ≤ 70 years
Ogata et al.26
Hupp et al.25
Savji et al.20
Hupp (unpublished) 
Subtotal (I2 = 90·7~)
Forsdahl et al.22
Age ≥ 81 years
Ogata et al.26
Hupp et al.25
Savji et al.20
Hupp (unpublished) 
Subtotal (I2 = 74·0~)
Prevalence (~)
2·01·51·00·50
Svensjo et al.27
Fig. 3 Prevalence of abdominal aortic aneurysm in women aged at least 60 years by 10-year age groups. All women were aged 70 years in
Svensjo et al.27. Values in parentheses are 95 per cent confidence intervals
Forsdahl et al.22
Ever smoker
Never smoker
Forsdahl et al.22
Reference Prevalence (~)
2·52 (1·70, 3·70)
1·71 (1·34, 2·19)
0·88 (0·57, 1·34)
0·79 (0·50, 1·25)
1·34 (0·82, 2·19)
0·52 (0·22, 1·24)
0·15 (0·07, 0·33)
1·05 (0·50, 2·18)
0·03 (0·00, 0·25)
0·28 (0·09, 0·93)
24·85
27·44
24·20
23·51
27·01
27·69
28·16
17·14
Weight (~)
Derubertis et al.29<
Derubertis et al.29<
Hupp (unpublished) 
Hupp (unpublished) 
Svensjo et al.27
Svensjo et al.27
Subtotal (I2 = 86·1~)
Subtotal (I2 = 83·8~)
Prevalence (~)
2·01·51·00·50 3·0
Fig. 4 Prevalence of abdominal aortic aneurysm in women aged at least 60 years by smoking status. *Derubertis and colleagues29
reported data on smoking status in a subgroup of patients from the study by Savji et al.; the analysis included 10 012 women, mean age
69 years, with at least one cardiovascular risk factor screened between 2004 and 2006. Values in parentheses are 95 per cent confidence
intervals
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heterogeneity even for these pooled estimates (I2 = 74–94
per cent), and in every age band the prevalence was lowest
in the self-referred cohorts and highest in the Norwegian
population register-based cohort. However, when relative
risks were assessed, there was more consistency between
studies (I2 = 0–49 per cent) than seen with the absolute
risks. Compared with those aged 70 years or less, the
prevalence was 2⋅7 (95 per cent c.i. 1⋅8 to 4⋅2) times higher
in the 71–80-years age group and 4⋅3 (4⋅0 to 4⋅7) times
higher among women aged 81 years or more.
Only five studies reported on prevalence by smoking
status (Table 2), although the recording of smoking status
was not uniform. Hupp (unpublished) recorded those who
remembered having smoked over 100 cigarettes in their
lifetime, which is the definition used by the US Preventive
ServicesTask Force37. The pooled prevalencewas lower for
never smokers (0⋅28 per cent) than for ever smokers (1⋅34
per cent) (Fig. 4). The study by Jahangir and colleagues30
provides support for this effect as the association between
AAA and former smoking had a hazard ratio of 3⋅4, rising
to 9⋅2 in current smokers. Three studies reported the
prevalence in current smokers: 2⋅08 per cent27, 4⋅63 per
cent22 and 2⋅82 per cent26. Two of the smaller studies27,29
reported similar prevalence for those with, and without
diabetes.
Discussion
Data on the population prevalence of AAA in women are
sparse and this systematic review identified only a handful
of studies conducted since 2000, with a pooled prevalence
of 0⋅74 (95 per cent c.i. 0⋅53 to 1⋅03) per cent in women
aged 60 years and over. This date limitation was introduced
because of the observed twofold reduction in prevalence
of screen-detected AAA in men between 1990 and now15.
Of the identified studies, only three invited women for
free screening based on population registers; the remain-
der recruited by advertisement, with self-referral screen-
ing being either sponsored or paid for by the woman
screened. This diversity in design implies that the popula-
tions screened were of diverse demographic characteristics,
particularly with respect to socioeconomic status, which
is likely to underlie part of the significant heterogeneity
between studies. For this reason, the physician-referred
screening in a largely uninsured southern US population
with high ethnic diversity is included as a comparator30.
The contemporary pooled prevalence of AAA in women
aged at least 60 years, reported here, appears to be lower
than that for earlier studies. For instance, in the pop-
ulation register-based Chichester (UK) screening trial2,
the prevalence in 65–80-year-old women in 1988–1990
was 1⋅3 per cent (but 1⋅7 per cent in those aged over
70 years).
This study also reports an increasing prevalence of AAA
with age and smoking, particularly for current smokers
where the prevalence appears to be over 2 per cent. Of
all the cardiovascular disorders, AAA has the strongest
association with smoking, particularly current smoking10.
The decline in smoking in those aged over 65 years has
been slower in women than in men8,13. The proportion
of current smokers varied in the different studies included
in this review, but was highest in Norway19, where the
prevalence of AAA was highest. Some of the difference in
overall prevalence between the neighbouring countries of
Norway19 and Sweden14 might be explained by differences
in smoking prevalence: 25 and 10 per cent respectively. The
high prevalence of AAA in women smokers was a notable
feature of the Jahangir study30, suggesting that smoking
may have a greater relative impact on prevalence in women
than in men. There was insufficient information in the
included studies to assess the impact of other risk factors.
Other contributions to heterogeneity might come from
the variable used for ultrasound diameter measurements:
anterior–posterior or transverse, based on inner-to-inner
wall, outer-to-outer wall or leading edge-to-leading edge.
Only one study27 was specific about the measurement
method reported.
All the data for this systematic review are based on the
definition of an AAA having a maximum infrarenal aor-
tic diameter of at least 3 cm on ultrasonography. This
definition has been derived for men, where 3⋅0 cm rep-
resents an approximately 50 per cent increase in normal
infrarenal aortic diameter. In men the median diameter of
those aged 65 years or more is 2⋅02 cm, whereas in women
aged at least 65 years the median infrarenal aortic diam-
eter is only 1⋅75 cm38. This begs the question whether
the diameter threshold for definition of an AAA should
be lower in women, perhaps 2⋅6 cm. If this were the case,
the screen-detected prevalence of AAA in women would
be much higher. For instance, with this lower diameter
threshold, the prevalence of AAA in 70-year-old Swedish
women would more than double27. Whether an aortic
diameter between 2⋅6 and 2⋅9 cm in women represents clin-
ically significant disease is unknown, and only studies with
long-term follow-up of this group will determine whether
there is any clinical benefit in refining the definition of an
AAA for women.
The data for the contemporary prevalence of AAA in
women should be considered in the context of the ongoing
debate about whether AAAs in women are diagnosed and
treated adequately. If AAA screening in 65-year-old men
is cost-effective down to a prevalence rate as low as 0⋅35
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per cent39, AAA screening also may be cost-effective in
70-year-old women, especially as the AAA rupture rate in
women is about four times that in men for a given AAA
diameter40. Indeed, a modelling study from Sweden41 has
already suggested that AAA screening for older women
would be cost-effective, based on an AAA prevalence of 1⋅1
per cent in 65-year-old women.
Present guidelines for AAA screening in women are
only that it is not recommended for older women who
have never smoked37. This contemporary review, show-
ing a pooled prevalence of 0⋅74 per cent in women aged
at least 60 years, rising to over 1⋅0 per cent in ever
smokers and those aged 70 years or older, might stimu-
late the debate about offering targeted AAA screening to
older women.
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